An update on Merck’s Sequivity vaccine technology for pigs
January 31, 2019 By Ken Anderson Filed Under: Innovations
At the recent Iowa Pork Congress in Des Moines, we visited with Brett O’Brien, sr. account manager in technical services for Merck Animal Health, about the company’s new Sequivity vaccine technology for pigs.
“(Sequivity)is an RNA particle technology that allows us to offer a rapid and precise response, with a vaccine that be customized for the veterinarians to use, to help tackle flu,” O’Brien says.
Audio: Brett O’Brien
Your email address will not be published.
Subscribe for our newsletter today and receive relevant news straight to your inbox!